This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Micro Biopharm Japan Co., Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Hiroki Kabumoto: Innovator in Microbial Conversion Technology
Introduction
Hiroki Kabumoto is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of microbial conversion technology. His innovative work focuses on improving bioconversion systems, which are essential for various industrial applications.
Latest Patents
Hiroki Kabumoto holds a patent for "Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them." This patent discloses a method for enhancing the poor conversion efficiency in conventional bioconversion systems. The invention involves using a transformant prepared by introducing a gene from xerogenic organisms into a host that is defective in a gene encoding a multidrug efflux protein. The use of this transformant significantly improves the microbial conversion of hydrophobic or amphipathic substrate compounds into desired products.
Career Highlights
Kabumoto is associated with Micro Biopharm Japan Co., Ltd., where he continues to advance research in microbial conversion technologies. His work has been instrumental in developing more efficient bioconversion processes, which are crucial for sustainable industrial practices.
Collaborations
Hiroki Kabumoto collaborates with notable colleagues, including Tadashi Fujii and Atsushi Ochiai. Their combined expertise contributes to the innovative research and development efforts at Micro Biopharm Japan Co., Ltd.
Conclusion
Hiroki Kabumoto's contributions to microbial conversion technology exemplify the importance of innovation in addressing industrial challenges. His patent and ongoing work continue to pave the way for advancements in bioconversion systems.